Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Ignacio I. Wistuba | Researchclopedia

Back to researchers

Ignacio I. Wistuba

Moffitt Cancer Center ORCID

2,828

Works

104,121

Citations

153

h-index

724

i10-index

Research Topics

Lung Cancer Treatments and Mutations RNA modifications and cancer Cancer Genomics and Diagnostics

Affiliations

AstraZeneca (United Kingdom)2013–2013

Broad Institute2008–2013

University of Notre Dame2020–2020

Boston University2010–2010

Northwestern University2012–2012

Top Works

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

William D. Travis,Élisabeth Brambilla,et al.

20114,805 citations

Cancer Immunotherapy and Biomarkers

Lung Cancer Research Studies

The 2015 World Health Organization Classification of Lung Tumors

William D. Travis,Élisabeth Brambilla,et al.

20154,464 citations

Somatic mutations affect key pathways in lung adenocarcinoma

Li Ding,Gad Getz,et al.

20082,732 citations

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

Mark G. Kris,Bruce E. Johnson,et al.

20141,726 citations

<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma

Ferdinandos Skoulidis,Michael E. Goldberg,et al.

20181,563 citations

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

Deborah B. Doroshow,Sheena Bhalla,et al.

20211,499 citations

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Hussein A. Tawbi,Melissa Burgess,et al.

20171,377 citations

Characterizing the cancer genome in lung adenocarcinoma

Barbara A. Weir,Michele Sue‐Ann Woo,et al.

20071,118 citations

An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Lauren A. Byers,Lixia Diao,et al.

20121,115 citations